151 related articles for article (PubMed ID: 18598019)
1. Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
Chen L; Zhang Y; Kong X; Lan E; Huang Z; Peng S; Kaufman DL; Tian J
J Med Chem; 2008 Aug; 51(15):4834-8. PubMed ID: 18598019
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anti-human hepatocellular carcinoma activity of new nitric oxide-releasing glycosyl derivatives of oleanolic acid.
Huang Z; Zhang Y; Zhao L; Jing Y; Lai Y; Zhang L; Guo Q; Yuan S; Zhang J; Chen L; Peng S; Tian J
Org Biomol Chem; 2010 Feb; 8(3):632-9. PubMed ID: 20090981
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-hepatocellular carcinoma activity of novel O
Zou Y; Yan C; Liu JC; Huang ZJ; Xu JY; Zhou JP; Zhang HB; Zhang YH
Chin J Nat Med; 2017 Dec; 15(12):928-937. PubMed ID: 29329650
[TBL] [Abstract][Full Text] [Related]
4. Hybrid molecule from O2-(2,4-dinitrophenyl)diazeniumdiolate and oleanolic acid: a glutathione S-transferase π-activated nitric oxide prodrug with selective anti-human hepatocellular carcinoma activity and improved stability.
Fu J; Liu L; Huang Z; Lai Y; Ji H; Peng S; Tian J; Zhang Y
J Med Chem; 2013 Jun; 56(11):4641-55. PubMed ID: 23617697
[TBL] [Abstract][Full Text] [Related]
5. Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity.
Ling Y; Ye X; Zhang Z; Zhang Y; Lai Y; Ji H; Peng S; Tian J
J Med Chem; 2011 May; 54(9):3251-9. PubMed ID: 21504204
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of furoxan-based nitric oxide-releasing derivatives of glycyrrhetinic acid as anti-hepatocellular carcinoma agents.
Lai Y; Shen L; Zhang Z; Liu W; Zhang Y; Ji H; Tian J
Bioorg Med Chem Lett; 2010 Nov; 20(22):6416-20. PubMed ID: 20932754
[TBL] [Abstract][Full Text] [Related]
7. YAP and 14-3-3γ are involved in HS-OA-induced growth inhibition of hepatocellular carcinoma cells: A novel mechanism for hydrogen sulfide releasing oleanolic acid.
Xu G; Wang J; Wu F; Wang N; Zhou W; Wang Q; Pan W; Ao G; Yang J
Oncotarget; 2016 Aug; 7(32):52150-52165. PubMed ID: 27437776
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
[TBL] [Abstract][Full Text] [Related]
9. Glycosylated diazeniumdiolate-based oleanolic acid derivatives: synthesis, in vitro and in vivo biological evaluation as anti-human hepatocellular carcinoma agents.
Huang Z; Fu J; Liu L; Sun Y; Lai Y; Ji H; Knaus EE; Tian J; Zhang Y
Org Biomol Chem; 2012 May; 10(19):3882-91. PubMed ID: 22473516
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Characterization and Anti-hepatoma Activity of New Hederagenin Derivatives.
Liu X; Sun L; Liu QH; Chen BQ; Liu YM
Mini Rev Med Chem; 2020; 20(3):252-257. PubMed ID: 32134368
[TBL] [Abstract][Full Text] [Related]
11. A library of 1,2,3-triazole-substituted oleanolic acid derivatives as anticancer agents: design, synthesis, and biological evaluation.
Wei G; Luan W; Wang S; Cui S; Li F; Liu Y; Liu Y; Cheng M
Org Biomol Chem; 2015 Feb; 13(5):1507-14. PubMed ID: 25476168
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel oxidative stress induced cell death by Sorafenib and oleanolic acid in human hepatocellular carcinoma cells.
Lange M; Abhari BA; Hinrichs TM; Fulda S; Liese J
Biochem Pharmacol; 2016 Oct; 118():9-17. PubMed ID: 27544320
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of the novel oleanolic acid-cinnamic acid ester derivatives and glycyrrhetinic acid-cinnamic acid ester derivatives with cytotoxic properties.
Wang R; Yang W; Fan Y; Dehaen W; Li Y; Li H; Wang W; Zheng Q; Huai Q
Bioorg Chem; 2019 Jul; 88():102951. PubMed ID: 31054427
[TBL] [Abstract][Full Text] [Related]
14. Interaction characteristics with bovine serum albumin and retarded nitric oxide release of ZCVI₄-2, a new nitric oxide-releasing derivative of oleanolic acid.
Zhang J; Gao Y; Su F; Gong Z; Zhang Y
Chem Pharm Bull (Tokyo); 2011; 59(6):734-41. PubMed ID: 21628910
[TBL] [Abstract][Full Text] [Related]
15. [Synthesis and biological evaluation of nitrate-oleanolic acid hybrids as inhibitors of HepG2 cell apoptosis].
Chen L; Shang J; Wang ZF; Zhang YH; Tian JD
Yao Xue Xue Bao; 2010 Dec; 45(12):1516-22. PubMed ID: 21351491
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxicity evaluation of oleanolic acid derivatives.
Hao J; Liu J; Wen X; Sun H
Bioorg Med Chem Lett; 2013 Apr; 23(7):2074-7. PubMed ID: 23434227
[TBL] [Abstract][Full Text] [Related]
17. Cotreatment with sorafenib and oleanolic acid induces reactive oxygen species-dependent and mitochondrial-mediated apoptotic cell death in hepatocellular carcinoma cells.
Liese J; Hinrichs TM; Lange M; Fulda S
Anticancer Drugs; 2019 Mar; 30(3):209-217. PubMed ID: 30640794
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and antitumor activity of oleanolic acid derivatives.
Meng YQ; Kuai ZY; Zhan SW; Li CL; Chen HR
J Asian Nat Prod Res; 2019 Jul; 21(7):633-651. PubMed ID: 29733221
[TBL] [Abstract][Full Text] [Related]
19. Oleanolic acid-NO donor-platinum(II) trihybrid molecules: Targeting cytotoxicity on hepatoma cells with combined action mode and good safety.
Fang L; Feng M; Chen F; Liu X; Shen H; Zhao J; Gou S
Bioorg Med Chem; 2016 Oct; 24(19):4611-4619. PubMed ID: 27501909
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel oleanolic acid and ursolic acid in C-28 position derivatives as potential anticancer agents.
Tian T; Liu X; Lee ES; Sun J; Feng Z; Zhao L; Zhao C
Arch Pharm Res; 2017 Apr; 40(4):458-468. PubMed ID: 28101738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]